NCT05675319 2026-01-05
AlloRelapseMM
Universitätsklinikum Hamburg-Eppendorf
Phase 3 Terminated
Clinical Trials
4 trialsNCT03720041 2021-06-15
FiTNEss
University of Leeds
Phase 3 Unknown
NCT03562169 2018-06-19
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
University of Leeds
Phase 3 Recruiting
NCT02406144 2017-11-30
Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma
PETHEMA Foundation
Phase 3 Completed